Patents by Inventor Robert Chorvat

Robert Chorvat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Azolo triazines and pyrimidines
    Patent number: 7678793
    Abstract: Corticotropin releasing factor (CRF) antagonists of formula I or II: and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.
    Type: Grant
    Filed: June 29, 2006
    Date of Patent: March 16, 2010
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Liqi He, Paul Gilligan, Robert Chorvat, Argyrios Georgios Arvanitis
  • MAO-B inhibitors useful for treating obesity
    Publication number: 20070088004
    Abstract: The invention provides novel compounds of formulae I and II: that are monoamine oxidase-B inhibitors, which can be useful in treating obesity, diabetes, and/or cardiometabolic disorders (e.g., hypertension, dyslipidemias, high blood pressure, and insulin resistance).
    Type: Application
    Filed: June 1, 2006
    Publication date: April 19, 2007
    Inventors: John McElroy, Robert Chorvat, Parthasarathi Rajagopalan
  • MAO-B INHIBITORS USEFUL FOR TREATING OBESITY
    Publication number: 20070078172
    Abstract: The invention provides a method of treating obesity, diabetes, and/or cardiometabolic disorders (e.g., hypertension, dyslipidemias, high blood pressure, and insulin resistance) in a mammal by administering to the mammal a therapeutically effective amount of an irreversible MAO-B inhibitor.
    Type: Application
    Filed: June 15, 2006
    Publication date: April 5, 2007
    Applicant: JENRIN DISCOVERY
    Inventors: John McElroy, Robert Chorvat, Rajagopalan Parthasarathi
  • MAO-B INHIBITORS USEFUL FOR TREATING OBESITY
    Publication number: 20070015734
    Abstract: The invention provides novel compounds of formula I: that are monoamine oxidase-B inhibitors, which can be useful in treating obesity, diabetes, and/or cardiometabolic disorders (e.g., hypertension, dyslipidemias, high blood pressure, and insulin resistance).
    Type: Application
    Filed: July 12, 2006
    Publication date: January 18, 2007
    Applicant: JENRIN DISCOVERY
    Inventors: John McElroy, Robert Chorvat, Rajagopalan Parthasarathi
  • MAO-B INHIBITORS USEFUL FOR TREATING OBESITY
    Publication number: 20070004683
    Abstract: The invention provides novel compounds of formulae I and II: that are monoamine oxidase-B inhibitors, which can be useful in treating obesity, diabetes, and/or cardiometabolic disorders (e.g., hypertension, dyslipidemias, high blood pressure, and insulin resistance).
    Type: Application
    Filed: June 30, 2006
    Publication date: January 4, 2007
    Applicant: JENRIN DISCOVERY
    Inventors: John McElroy, Robert Chorvat, Rajagopalan Parthasarathi
  • Azolo triazines and pyrimidines
    Publication number: 20060252756
    Abstract: Corticotropin releasing factor (CRF) antagonists of formula I or II: and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.
    Type: Application
    Filed: June 29, 2006
    Publication date: November 9, 2006
    Inventors: Liqi He, Paul Gilligan, Robert Chorvat, Argyrios Arvanitis
  • Azolo triazines and pyrimidines
    Patent number: 7094782
    Abstract: Corticotropin releasing factor (CRF) antagonists of formula I or II: and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.
    Type: Grant
    Filed: November 7, 2003
    Date of Patent: August 22, 2006
    Assignee: Bristol-Myers Squibb Company
    Inventors: Liqi He, Paul Gilligan, Robert Chorvat, Argyrios Georgios Arvanitis
  • Azolo triazines and pyrimidines
    Publication number: 20030008885
    Abstract: Corticotropin releasing factor (CRF) antagonists of formula I or II: 1
    Type: Application
    Filed: August 16, 2001
    Publication date: January 9, 2003
    Inventors: Liqi He, Paul Gilligan, Robert Chorvat, Argyrios Arvanitis
  • Azolo triazines and pyrimidines
    Patent number: 6358950
    Abstract: Corticotropin releasing factor (CRF) antagonists of formula I or II: and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.
    Type: Grant
    Filed: October 26, 2000
    Date of Patent: March 19, 2002
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Liqi He, Paul Gilligan, Robert Chorvat, Argyrios Georgios Arvanitis
  • Tetrazine bicyclic compounds
    Patent number: 6313124
    Abstract: Corticotropin releasing factor (CRF) antagonists of formula I or II: and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.
    Type: Grant
    Filed: January 28, 1998
    Date of Patent: November 6, 2001
    Assignee: DuPont Pharmaceuticals Company
    Inventors: Liqi He, Paul Gilligan, Robert Chorvat, Argyrios Georgios Arvanitis
  • Azolo triazines and pyrimidines
    Patent number: 6191131
    Abstract: Corticotropin releasing factor (CRF) antagonists of formula I or II: and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.
    Type: Grant
    Filed: January 28, 1998
    Date of Patent: February 20, 2001
    Assignee: DuPont Pharmaceuticals Company
    Inventors: Liqi He, Paul Gilligan, Robert Chorvat, Argyrios Georgios Arvanitis
  • Azolo triazines and pyrimidines
    Patent number: 6136809
    Abstract: Corticotropin releasing factor (CRF) antagonists of formula I or II: ##STR1## and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.
    Type: Grant
    Filed: January 28, 1998
    Date of Patent: October 24, 2000
    Assignee: Dupont Pharmaceuticals
    Inventors: Paul Gilligan, Robert Chorvat
  • Azolo triazines and pyrimidines
    Patent number: 6060478
    Abstract: Corticotropin releasing factor (CRF) antagonists of formula I or II: ##STR1## and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.
    Type: Grant
    Filed: January 28, 1998
    Date of Patent: May 9, 2000
    Assignee: DuPont Pharmaceuticals
    Inventors: Paul Gilligan, Robert Chorvat, Argyrios Georgios Arvanitis